An exhaustive review of more than 8,000 participants reveals how teenage cannabis use can reshape the developing brain, raising urgent questions about long-term risks and early intervention.
Research: How adolescent cannabis use reshapes the developing brain – a systematic review. Image credit: aleks333/Shutterstock.com
Recent systematic reviews published in frontiers of psychiatry report that adolescent cannabis use is associated with structural brain differences, increased risk of addiction, and a mix of cognitive outcomes. Some evidence suggests that adolescence may be a “critical period” of heightened vulnerability.
Increased teenage cannabis use during sensitive neurodevelopmental stages
Adolescence is characterized by various developmental changes in the brain that are essential for cognitive and neuropsychiatric abilities. At the same time, it becomes more susceptible to environmental influences.
The endocannabinoid system plays an important role in brain development during adolescence. Cannabinoid CB1 receptor expression The prefrontal and limbic regions of the brain reach their peak during this period, making them more susceptible to cannabis exposure.
Cannabis use among adolescents has increased significantly over the past two decades, primarily due to changes in legal structures and decreased risk perception. Existing evidence indicates that both the timing and frequency of cannabis use can negatively impact adolescent neurodevelopment.
Given the increasing prevalence of cannabis among adolescents and its significant neuropsychiatric consequences, an Italian research team conducted a systematic review to assess the neurodevelopmental consequences of cannabis use in adolescents.
The researchers searched the PubMed, EMBASE, PsycINFO, and Web of Science databases to screen for studies that investigated the structural, cognitive, and neuropsychiatric effects of cannabis on the brain in adolescent populations. This resulted in the selection of 36 studies involving 8,432 participants for final review. Of these studies, 23 were longitudinal studies, 8 were cross-sectional studies, 4 were randomized controlled trials, and 1 was a case-control study.
Early cannabis use is associated with structural brain differences
Results from neuroimaging studies revealed dose-dependent changes in brain structure after cannabis use, including decreased prefrontal cortex, hippocampus, and amygdala volumes, increased cortical thinning, and impaired white matter connectivity that correlated with age at onset of cannabis use. These findings support the idea that cannabis exposure during adolescence may interact with ongoing brain maturation processes, rather than simply affecting the fully developed brain.
In this context, genetic studies have shown that mutations in the cannabinoid receptor 1 (CNR1) gene are associated with reduced hippocampal volume, particularly in cannabis users, suggesting a genetic predisposition to structural changes in the brain.
Cognitive studies have had mixed results. Some studies have reported persistent cognitive impairment even after long periods of abstinence, while others have reported no effect even after controlling for confounders. In this context, studies have revealed that early-onset users (under 17 years of age) have lower cognitive performance compared to late-onset users, even after 28 days of abstinence. These findings suggest possible long-term neurotoxic effects of cannabis in adolescents.
However, twin studies that adjusted for familial confounders suggest that cognitive impairment in adolescents may reflect common genetic and environmental factors rather than a direct effect of cannabis, highlighting the importance of pre-existing vulnerabilities such as socioeconomic, psychiatric, and familial influences.
Several studies have reported significant gender-specific differences in cannabis-related cognitive outcomes. Recent cannabis use was associated with worse episodic memory only in women, and lifetime and recent use was associated with worse decision-making only in men.
Regarding the reversibility of cognitive effects, randomized controlled trials revealed significant improvements in verbal memory during the first week of abstinence, highlighting the rapid recovery of cognitive abilities after abstinence in adolescents. However, for some early-onset patients, long-term recovery may remain incomplete.
Epidemiological studies have revealed an increased risk of addiction. Reduced release of the neurotransmitter dopamine in the brain in response to early cannabis use in adolescence was found to be associated with reduced dopamine signaling, suggesting that permanent changes may occur in the brain’s reward processing system. Such disruptions in dopaminergic signaling can have significant long-term effects, including increased cannabis addiction and the emergence of a wide range of addictive behaviors over the course of a lifetime.
Studies examining long-term outcomes have found educational difficulties, lack of employment and income, low life satisfaction, relationship problems, mental health problems such as anxiety, increased risk of psychosis-related outcomes (although some associations were attenuated after accounting for pre-existing vulnerabilities), and functional impairment. However, due to the observational study design, the causal relationship between cannabis use and these long-term outcomes remained unclear. And findings varied widely depending on study design, population characteristics, and how cannabis exposure was measured.
Study variability limits clear interpretation of cannabis effects
The studies included in this review have significant differences in study design, definition of cannabis use, age and frequency of cannabis use, population characteristics, and outcome measures, limiting accurate interpretation of the results.
Another limitation is publication bias. Studies reporting significant adverse effects of cannabis are more likely to be published than studies reporting no effects. This may increase the apparent effect size.
Adolescence is a key window for cannabis risk
This systematic review shows that adolescence serves as a critical period for increasing cannabis sensitivity, with early initiation and long-term use potentially enabling cannabis use. It may be related to changes in neurodevelopment.
The incomplete cognitive recovery observed among early-onset users highlights the need to develop cognitive rehabilitation interventions that target brain processing speed, working memory, and executive function in people at risk. Further research is needed to establish the effectiveness of such an approach.
The rapid evolution of addictive behaviors among adolescent users highlights the need for easily accessible early interventions that can rapidly engage adolescents and provide comprehensive support during the critical early months of use.
In particular, the influence of common genetic and environmental factors on cannabis-related outcomes in adolescents highlights the need for a collaborative approach involving health care providers, schools, families, and community organizations to create a supportive environment that promotes healthy development.
Click here to download your PDF copy.
